Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis.

Autor: Hartkopf AD; Department of Women's Health, University of Tuebingen, Tuebingen, Germany. Electronic address: andreas.hartkopf@med.uni-tuebingen.de., Brucker SY; Department of Women's Health, University of Tuebingen, Tuebingen, Germany., Taran FA; Department of Women's Health, University of Tuebingen, Tuebingen, Germany; Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany., Harbeck N; Breast Center, Department of Obstetrics and Gynecology, University of Munich (LMU), Munich, Germany., von Au A; Department of Gynecology and Obstetrics, Heidelberg University Hospital, National Center for Tumor Diseases (NCT) Heidelberg, Germany., Naume B; Department of Oncology, Oslo University Hospital and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Pierga JY; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France., Hoffmann O; Department of Gynecology and Obstetrics, University Hospital of Essen, Essen, Germany., Beckmann MW; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Germany., Rydén L; Department of Clinical Sciences Lund, Division of Oncology-Pathology and Surgery, Lund University, Lund, Sweden., Fehm T; Department of Gynecology and Obstetrics, Duesseldorf University Hospital, Duesseldorf, Germany., Aft R; Washington University, St. Louis, MO, USA., Solà M; Department of Nuclear Medicine, Hospital Germans Trias I Pujol, Badalona, Spain., Walter V; Department of Women's Health, University of Tuebingen, Tuebingen, Germany., Rack B; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany., Schuetz F; Department of Gynecology and Obstetrics, Heidelberg University Hospital, National Center for Tumor Diseases (NCT) Heidelberg, Germany., Borgen E; Department of Pathology, Oslo University Hospital, Oslo, Norway., Ta MH; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France; University of Medicine Paris Descartes, Paris, France., Bittner AK; Department of Gynecology and Obstetrics, University Hospital of Essen, Essen, Germany., Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Germany., Fernö M; Department of Clinical Sciences Lund, Oncology-Pathology, Lund University, Lund, Sweden., Krawczyk N; Department of Gynecology and Obstetrics, Duesseldorf University Hospital, Duesseldorf, Germany., Weilbaecher K; Washington University, St. Louis, MO, USA., Margelí M; ICO-Badalona, Medical Oncology Service, B-ARGO, Badalona, Spain., Hahn M; Department of Women's Health, University of Tuebingen, Tuebingen, Germany., Jueckstock J; Breast Center, Department of Obstetrics and Gynecology, University of Munich (LMU), Munich, Germany., Domschke C; Department of Gynecology and Obstetrics, Heidelberg University Hospital, National Center for Tumor Diseases (NCT) Heidelberg, Germany., Bidard FC; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France., Kasimir-Bauer S; Department of Gynecology and Obstetrics, University Hospital of Essen, Essen, Germany., Schoenfisch B; Department of Women's Health, University of Tuebingen, Tuebingen, Germany., Kurt AG; Breast Center, Department of Obstetrics and Gynecology, University of Munich (LMU), Munich, Germany., Wallwiener M; Department of Gynecology and Obstetrics, Heidelberg University Hospital, National Center for Tumor Diseases (NCT) Heidelberg, Germany., Gebauer G; Department of Gynecology and Obstetrics, Asklepios Klinik Barmbek, Nord-Heidberg and Wandsbek, Hamburg, Germany., Klein CA; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany., Wallwiener D; Department of Women's Health, University of Tuebingen, Tuebingen, Germany., Janni W; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany., Pantel K; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Sep; Vol. 154, pp. 128-137. Date of Electronic Publication: 2021 Jul 12.

Biphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cells.

Autor: Kutuk O; Department of Medical Genetics, Baskent University School of Medicine, Adana Dr. Turgut Noyan Medical and Research Center, Adana, Turkey., Aytan N; Department of Neurology, Boston University School of Medicine, Boston, United States of America., Karakas B; Molecular Biology, Genetics and Bioengineering Program, Sabanci University, Istanbul, Turkey., Kurt AG; Department of Medical Genetics, Baskent University School of Medicine, Adana Dr. Turgut Noyan Medical and Research Center, Adana, Turkey., Acikbas U; Department of Medical Genetics, Baskent University School of Medicine, Adana Dr. Turgut Noyan Medical and Research Center, Adana, Turkey., Temel SG; Department of Histology and Embryology, Uludag University School of Medicine, Bursa, Turkey.; Department of Histology and Embryology, Near East University School of Medicine, Nicosia, Northern Cyprus., Basaga H; Molecular Biology, Genetics and Bioengineering Program, Sabanci University, Istanbul, Turkey.

Publikováno v: PloS one [PLoS One] 2017 Aug 10; Vol. 12 (8), pp. e0182809. Date of Electronic Publication: 2017 Aug 10 (Print Publication: 2017).

Production of L-DOPA and dopamine in recombinant bacteria bearing the Vitreoscilla hemoglobin gene.

Autor: Kurt AG; Department of Biology, Inonu University, Malatya, Turkey., Aytan E, Ozer U, Ates B, Geckil H

Publikováno v: Biotechnology journal [Biotechnol J] 2009 Jul; Vol. 4 (7), pp. 1077-88.